Volume 80, Issue 12, Pages (December 2011)

Slides:



Advertisements
Similar presentations
Volume 70, Issue 1, Pages (July 2006)
Advertisements

Volume 67, Issue 2, Pages (February 2005)
Two-photon microscopy: Visualization of kidney dynamics
Mesenchymal Stem Cells Ameliorate Podocyte Injury and Proteinuria in a Type 1 Diabetic Nephropathy Rat Model  Shuai Wang, Yi Li, Jinghong Zhao, Jingbo.
Volume 64, Issue 6, Pages (December 2003)
Mesenchymal Stem Cells Ameliorate Podocyte Injury and Proteinuria in a Type 1 Diabetic Nephropathy Rat Model  Shuai Wang, Yi Li, Jinghong Zhao, Jingbo.
Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria  Dan Wang, Chunsun Dai, Yingjian Li, Youhua.
Volume 63, Issue 4, Pages (April 2003)
Volume 85, Issue 4, Pages (April 2014)
Volume 77, Issue 11, Pages (June 2010)
Yihan Wang, Michael A. Shia, Thomas G. Christensen, Steven C. Borkan 
Volume 62, Issue 6, Pages (December 2002)
Volume 58, Issue 3, Pages (September 2000)
Volume 72, Issue 6, Pages (September 2007)
C.B. Marshall, J.W. Pippin, R.D. Krofft, S.J. Shankland 
Volume 83, Issue 1, Pages (January 2013)
Volume 64, Issue 1, Pages (July 2003)
Volume 90, Issue 1, Pages (July 2016)
Characterization of proteinuria and tubular protein uptake in a new model of oral L-lysine administration in rats  K. Thelle, E.I. Christensen, H. Vorum,
Volume 60, Issue 2, Pages (August 2001)
Volume 85, Issue 2, Pages (January 2014)
Volume 71, Issue 6, Pages (March 2007)
Proteomic analysis of the slit diaphragm complex: CLIC5 is a protein critical for podocyte morphology and function  Brian A. Pierchala, Maura R. Muñoz,
Volume 81, Issue 5, Pages (March 2012)
Volume 75, Issue 2, Pages (January 2009)
Pdlim2 is a novel actin-regulating protein of podocyte foot processes
Hua Liu, Steven A. Bigler, Jeffrey R. Henegar, Radhakrishna Baliga 
Volume 83, Issue 4, Pages (April 2013)
Volume 78, Issue 2, Pages (July 2010)
CD44-mediated neutrophil apoptosis in the rat
Serine 269 phosphorylated aquaporin-2 is targeted to the apical membrane of collecting duct principal cells  Hanne B. Moeller, Mark A. Knepper, Robert.
Volume 83, Issue 6, Pages (June 2013)
Volume 60, Issue 4, Pages (October 2001)
Ailian Liu, Alan Dardik, Barbara J. Ballermann  Kidney International 
Volume 61, Issue 4, Pages (April 2002)
Volume 60, Issue 3, Pages (September 2001)
In vivo visualization of albumin degradation in the proximal tubule
A new mouse model of immune-mediated podocyte injury
Volume 73, Issue 8, Pages (April 2008)
Volume 62, Issue 1, Pages (July 2002)
Volume 76, Issue 4, Pages (August 2009)
Volume 61, Issue 1, Pages (January 2002)
Volume 63, Issue 4, Pages (April 2003)
Volume 67, Issue 5, Pages (May 2005)
Volume 70, Issue 1, Pages (July 2006)
Volume 60, Issue 6, Pages (December 2001)
Volume 67, Issue 2, Pages (February 2005)
Renoprotective role of the vitamin D receptor in diabetic nephropathy
Volume 54, Issue 2, Pages (August 1998)
Chun Shia Chang, R. Gary Kirk, Ping Lee  Kidney International 
Volume 74, Issue 5, Pages (September 2008)
Volume 70, Issue 11, Pages (December 2006)
Volume 67, Issue 4, Pages (April 2005)
Volume 61, Issue 6, Pages (June 2002)
Wei-Zhong Ying, Pei-Xuan Wang, Paul W. Sanders  Kidney International 
Volume 72, Issue 3, Pages (August 2007)
Volume 71, Issue 7, Pages (April 2007)
Volume 56, Issue 6, Pages (December 1999)
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis  H.-C. Yang, L.-J. Ma, J. Ma, A.B. Fogo 
Volume 80, Issue 5, Pages (September 2011)
Distribution of postsynaptic density proteins in rat kidney: Relationship to neuronal nitric oxide synthase  Akihiro Tojo, David S. Bredt, Christopher.
Volume 68, Issue 2, Pages (August 2005)
Nestin expression in the kidney with an obstructed ureter
Effects of NADPH oxidase inhibitor in diabetic nephropathy
Volume 69, Issue 11, Pages (June 2006)
Volume 85, Issue 1, Pages (January 2014)
Two-photon microscopy: Visualization of kidney dynamics
Volume 72, Issue 4, Pages (August 2007)
Volume 55, Issue 4, Pages (April 1999)
Volume 56, Issue 6, Pages (December 1999)
Presentation transcript:

Volume 80, Issue 12, Pages 1328-1338 (December 2011) Selective albuminuria via podocyte albumin transport in puromycin nephrotic rats is attenuated by an inhibitor of NADPH oxidase  Satoshi Kinugasa, Akihiro Tojo, Tatsuo Sakai, Harukuni Tsumura, Masafumi Takahashi, Yasunobu Hirata, Toshiro Fujita  Kidney International  Volume 80, Issue 12, Pages 1328-1338 (December 2011) DOI: 10.1038/ki.2011.282 Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 1 Renal uptake of injected Evans Blue (EB)-labeled human serum albumin is increased in puromycin aminonucleoside (PAN) nephrotic rats. Images of kidneys after continuous injection for 90min in controls (a, c) and PAN nephrotic rats (b, d). (a, b) Light micrographs of vibratome sections of rat kidneys. (c, d) Confocal images showing localization of EB-labeled human serum albumin in 5μm Lowicryl sections. Uptake of EB-labeled human serum albumin was markedly increased in podocytes and proximal tubular cells. The degree of uptake was heterogenous among podocytes. Bar=50μm. Kidney International 2011 80, 1328-1338DOI: (10.1038/ki.2011.282) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 2 Twenty-four hours renal clearance study after a single injection of Evans Blue-labeled human serum albumin (EB-HSA) in controls, nephrotic rats induced by puromycin aminonuculeoside (PAN) at 5 days, and PAN rats treated with apocynin starting 2 days before PAN injection (PAN+apocynin). (a) Measurement of 24h urinary EB-labeled human serum albumin excretion and proteinuria. Data are shown as mean±s.e.m. **P<0.01 versus control. ‡P<0.05, ‡‡P<0.01 versus PAN. (b) Western blotting for human serum albumin of microdissected glomeruli. Uptake of albumin by glomerular cells was increased in PAN nephrotic rats. (c) SDS-PAGE for urine. (d) Densitometry was performed to calculate the urinary IgG/albumin ratio, in order to compare the selectivity of urinary proteins. Each group includes five rats. Cr, creatinine. Kidney International 2011 80, 1328-1338DOI: (10.1038/ki.2011.282) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 3 Immunogold transmission electron microscopy (TEM) images labeling for Evans Blue-labeled human serum albumin in the podocytes. In the control (a), there were hardly any immunogold particles in podocytes. Many gold particles were present in podocyte vesicles (b), apical protrusions (c), microvilli (d), and vesicles just about to be excreted from the apical membrane (e) in puromycin aminonuculeoside (PAN) nephrotic rats. GBM, glomerular basement membrane. Bar=100nm. Kidney International 2011 80, 1328-1338DOI: (10.1038/ki.2011.282) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 4 Podocyte albumin transport as visualized by immunogold scanning electron microscope (SEM). (a–d) Immunogold SEM against human serum albumin after 90min of injection in controls (a, c) and puromycin aminonucleoside (PAN) nephrotic rats (b, d). Many gold particles are present in cytoplasmic vesicles and on the cell surface of podocytes in PAN nephrotic rats. (e, f) Secondary electron images of the podocyte surface at high magnification. Many granular protrusions are seen on the podocyte surface in PAN nephrotic rats (f), whereas these are absent in controls (e). C, glomerular capillary; P, podocyte; U, urinary space; V, vesicle. Each group includes four rats. Bars=1μm (a–d), 500nm (e, f). Kidney International 2011 80, 1328-1338DOI: (10.1038/ki.2011.282) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 5 Reactive oxygen species (ROS) production by NADPH oxidase in controls, puromycin aminonucleoside (PAN) nephrotic rats, and PAN rats treated with apocynin (PAN+apocynin). (a) Light micrographs (top, toluidine blue staining) and electron micrographs (bottom) of Lowicryl sections prepared for pre-embedding immunoelectron microscopy for the NADPH oxidase subunit p47phox. The inset shows an enlargement of the podocytes stained for p47phox. (b) Measurement of urinary hydrogen peroxide (H2O2) levels and proteinuria. **P<0.01 versus control; +P<0.05, ++P<0.01 versus PAN-2d; #P<0.05, ##P<0.01 versus PAN-7d, $$P<0.01 versus PAN-7d, ‡P<0.05 versus PAN+apocynin. (c) Detection of ROS by cerium chloride histochemistry. Cerium chloride precipitation indicating superoxide production was observed on the plasma membrane of podocytes, the glomerular basement membrane, and endothelial cells on day 2 after puromycin injection in PAN nephrotic rats, which decreased with treatment by apocynin. Each group includes four to eight rats. Bars=50μm (a, top), 200nm (a, bottom), and 500nm (c). BW, body weight; Cr, creatinine. Kidney International 2011 80, 1328-1338DOI: (10.1038/ki.2011.282) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 6 Effect of apocynin on endocytosis and excretion of Evans Blue (EB)-labeled human serum albumin. (a–f) Observation by immunogold transmission electron microscopy (TEM) (a, b) and scanning electron microscope (SEM) (c–f) methods in puromycin aminonucleoside (PAN) nephrotic rats untreated (n=8, a, c, e), or treated with apocynin (PAN+ apocynin, n=5, b, d, f) on day 5 after disease induction. C, glomerular capillary; P, podocyte; U, urinary space; V, vesicle. (g) Comparison of the number of immunogold particles labeling for EB-labeled human serum albumin within the podocyte cytoplasm, podocyte vesicles, and on the surface of podocytes in electron micrographs. A total of 30–50 images from kidney samples of three rats in each group were analyzed. **P<0.01 versus control. ‡P<0.05, ‡‡P<0.01 versus PAN. Bars=500nm (a, b) and 1μm (c–f). Kidney International 2011 80, 1328-1338DOI: (10.1038/ki.2011.282) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 7 Renal handling of Evans Blue (EB)-labeled human serum albumin in green fluorescent protein (GFP) transgenic rats. (a) Real-time confocal microscopic images of the renal tubules after injection of EB-labeled human serum albumin in puromycin aminonucleoside (PAN) nephrotic GFP transgenic rats and their controls. EB fluorescence appeared immediately in the peritubular capillaries (arrowheads), and later in the tubular lumen (indicated by asterisks) after 5min in PAN rats, but not in the control. (b) Confocal microscopic images of glomeruli in vibratome sections. Podocytes uptaking EB-labeled human serum albumin turned yellow (arrowheads) in PAN nephrotic rats, whereas podocytes without EB-labeled human serum albumin endocytosis showed GFP fluorescence in controls (arrows). The degree of podocyte EB-labeled human serum albumin uptake was heterogenous among cells. Bar=50μm. Kidney International 2011 80, 1328-1338DOI: (10.1038/ki.2011.282) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 8 Role of FcRn as an albumin receptor in the podocyte. (a) Immunoprecipitation analysis of isolated glomeruli with anti-FcRn antibody. (b) SDS-PAGE of urinary protein from puromycin aminonucleoside (PAN) nephrotic rats (n=3) and PAN nephrotic rats treated with antibody against rat FcRn (PAN+FcRn Ab, n=3) at day 5. (c) Amount of urinary protein per mg creatinine. ‡P<0.05 versus PAN. (d) Confocal microscopic images of glomeruli in Lowicryl sections after 15min of Evans Blue-labeled human serum albumin. Podocytes are marked by arrowheads. Bar=50μm. Kidney International 2011 80, 1328-1338DOI: (10.1038/ki.2011.282) Copyright © 2011 International Society of Nephrology Terms and Conditions